In-Vitro Diagnostic Summit 2010

In general, IVD is at the forefront of medical services and research, and is a key area of preventive medicine R&D. China, as one of the most important IVD markets, has fostered competitive IVD firms in recent years and developed new technologies and products. The IVD market of China was in double-digit growth in the past decade, and was deemed as the most promising market in Asia.

CBI and BIOON.COM have joined hands to present 2010 IVD Summit. Scientific, pragmatic, authoritative and up-to-date expertise and technologies will be shared at this conference. The participants will have great opportunities to network with one another, and get a thorough update about the policies and market. Cases will be studies to demonstrate how cutting-edge technologies have been turned into commercial success.

Market players thoroughout the whole industrail chain will attend, including
1. IVD manufacturers / operators;
2. R&D institutes and universities;
3. Industrial authorities and government departments;
4. Clinical test institutions;
5. Investors / venture capitalists for bio-pharmaceutical industry;
6. Life science solution providers;
7. Consultancy firms;